I agree but Coilin's predicament stems from the fact that there is
both a "sponzor" and "zadavatel" in this study, two separate entities.
I think that's the confusing part. So we were suggesting maybe in this
particular case it sounds like the party Coilin's text calls
"zadavatel" does what usually the "principal investigator" would do.

Tom

James Kirchner

Has anyone looked on the websites of pharmaceutical development consultants and seen if there s something there? Jamie ... [Non-text portions of this message

Message 3 of 18
, Nov 6, 2007

0 Attachment

Has anyone looked on the websites of pharmaceutical development
consultants and seen if there's something there?

Jamie

On Nov 6, 2007, at 10:19 AM, tomas_barendregt wrote:

> --- In Czechlist@yahoogroups.com, Sabina Kr�lov� <Sabina.Kralova@...>
> wrote:
> >
> > I know I am rather late and I did not follow this - but there is a
> standard
> > translation for
> > principal investigator - hlavni zku�ej�c�
> > sponsor - zadavatel
>
> I agree but Coilin's predicament stems from the fact that there is
> both a "sponzor" and "zadavatel" in this study, two separate entities.
> I think that's the confusing part. So we were suggesting maybe in this
> particular case it sounds like the party Coilin's text calls
> "zadavatel" does what usually the "principal investigator" would do.
>
> Tom
>
>
>

[Non-text portions of this message have been removed]

coilinoc

Thanks for the additional input, guys. The more I look at it, the more I think that zadavatel is indeed the sponsor in the sense of the Act on

Message 4 of 18
, Nov 6, 2007

0 Attachment

Thanks for the additional input, guys.
The more I look at it, the more I think that "zadavatel" is indeed the
"sponsor" in the sense of the Act on Pharmaceuticals in that it
coordinates all aspects of the study. I'm beginning to think that they
put this clause in to ensure that this sponsorship is not confused
with the role of the other party who is simply a financial
sponsor/backer or patron of the research.
Still hard to come up with a two different terms in English, though...
C.

--- In Czechlist@yahoogroups.com, James Kirchner <jpklists@...> wrote:
>
> Has anyone looked on the websites of pharmaceutical development
> consultants and seen if there's something there?
>
> Jamie
>
> On Nov 6, 2007, at 10:19 AM, tomas_barendregt wrote:
>
> > --- In Czechlist@yahoogroups.com, Sabina Králová <Sabina.Kralova@>
> > wrote:
> > >
> > > I know I am rather late and I did not follow this - but there is a
> > standard
> > > translation for
> > > principal investigator - hlavni zkuející
> > > sponsor - zadavatel
> >
> > I agree but Coilin's predicament stems from the fact that there is
> > both a "sponzor" and "zadavatel" in this study, two separate entities.
> > I think that's the confusing part. So we were suggesting maybe in this
> > particular case it sounds like the party Coilin's text calls
> > "zadavatel" does what usually the "principal investigator" would do.
> >
> > Tom
> >
> >
> >
>
>
>
> [Non-text portions of this message have been removed]
>

>
> Thanks for the additional input, guys.
> The more I look at it, the more I think that "zadavatel" is indeed the
> "sponsor" in the sense of the Act on Pharmaceuticals in that it
> coordinates all aspects of the study. I'm beginning to think that they
> put this clause in to ensure that this sponsorship is not confused
> with the role of the other party who is simply a financial
> sponsor/backer or patron of the research.
> Still hard to come up with a two different terms in English, though...

Underwriter (for the financing sponsor)?

Your message has been successfully submitted and would be delivered to recipients shortly.